- (PLX AI) - Merck KGaA second-quarter earnings are likely to beat consensus estimates and the company may raise its full-year outlook, analysts at Bank of America forecast.
- • We see a big Q2 beat on EBITDA and EPS, driven by Life Science and Process Solutions, Bank of America said
- • Merck KGaA currently guides for full-year EBITDA of EUR 5.4-5.8 billion; the upper end of the guidance may be raised to EUR 5.9 billion or more, BofA said
- • Merck KGaA is scheduled to report earnings on Aug. 5